US senator says diabetes and weight-loss drug changed his life, here’s why

US Senator said Drugs GLP-1 changed his life now calls for a wide access to obesity medication.

In the New York Times OP-ed 8 April, Senator John Fetterman, D-Pa, wrote about his experience with Mounjar (Tirzepatide).

The prescription medicine is primarily used to treat type 2 diabetes.

Health benefits of Orempic are still growing, but are the risks?

Fetterman’s drugs are prescribed in July 2025.

“As Surviving strokeI was interested in the studies that show [Mounjaro] It could significantly reduce the risk of major heart events, “the senator wrote.

“Although I started taking it for my Heart healthI hit how much better I felt I was feeling all over the board. He made a significant impact on my overall health, “he continued.

“Pain, pain and stiffness are gone. Physically, I feel a decade younger, as well as more clearly and more optimistic than I have been in the years. As far as side effects are concerned, I also lost about 20 pounds.”

Genetic cholesterol eliminated with a new drug, reducing the risk of heart attack, are found

In addition to reducing blood sugar, GLP-1 drugs are also associated with a number of other advantages, including improved heart health, neurological function and metabolic health, as Fox News Digital reported.

Eli Lilly, Mounjara manufacturer, also offers another version of a drug called Zepbound, which is the same drug approved for weight loss, chronic weight management and sleep apnea.

Other GLP-1 drugs include Ozepic, Wegovy, Victoza, Saxenda, and was made by New Nordisk.

Fetterman noted that GLP-1 drugs were found to have useful effects on cholesterol, heartbeat and heart inflammation.

“Some recent studies suggest that they could even help the curb alcohol addiction And they support cognitive function, potential slowing or preventing conditions such as Parkinson’s and Alzheimer’s, “he wrote to The Times op-ed.

“Physically, I feel a decade younger, as well as clearer and more optimistic than I’ve been for years.”

In OP-ed, Fetterman called for an extended approach These drugswhich can cost up to $ 1,000 from pocket if not covered by insurance.

“Currently, Medicare covers these medicines only under certain circumstances, such as diabetes or increased risk of heart,” he wrote. “And the coverage of Medicaid is even more limited.”

Fetterman added that he was not compensated for sharing his experience.

Orempic ‘Microdose’ is a new trend of weight loss

“I’m just a guy who has benefited from these drugs and wants to ensure that everyone else who can benefit from them can have access to them,” he wrote.

While Fetterman shares HHS sec. Robert F. Kennedy Jr. The attitudes of nutrition and healthy life’s priorities, said he believed that medicines are needed.

“I completely agree with these diets and Lifetime style – A lot. But the diet itself is not enough, “he wrote.

“For millions of Americans struggling with serious health problems, medicines can be crucial to the first step to returning enough control over their health to start significant changes in lifestyle.”

Doctors discusses the benefits and approach

Dr. Marc Siegel, Clinical Professor of Medicine at NYU Langone Health and Fox News’ Senior Medical Analyst, said that semaglutides, including Orempic and Wegovy, “very important medicines” for Type 2 diabeteswith increasing use for obesity.

“Although these drugs seem useful use for the heart and lipid profile – as well as the brain and reduction of the risk of dementia – studies are ongoing and more information is needed,” he told Fox News Digital.

First an approach to obesity Is it way of life, including exercise, improved diet and optimal sleep, Siegel said.

“Having said that, these weight loss medicines (including Zepbound) are also good tools when lifestyle is not enough,” he noticed.

“They help prevent the diseases that are below, such as heart disease, stroke, high blood pressure and apnea during sleep, which tend to come out of obesity.”

He added: “Generally, we save money to the health system, so I would like Medicare and Medicaid to approve of diabetes and weight loss. “

Click here to sign up for our Health Bulletin

Dr. Brett Osborn, a florid neurologist and an expert in longevity, said he has been prescribed by GLP-1 since 2019.

“Mounjaro and his relatives are not just weight loss tools-they are buttons for resetting metabolic resets,” he told Fox News Digital.

“People with metabolic syndrome do not need lectures on kale and the importance of exercise. They need help.”

Osborn agreed that the lifestyle is necessary, but it is “rarely enough”.

“GLP-1 give patients swinging by rolling the ball,” he said. “And when this happens, health habits are formed. Diet improves. The movement improves. People begin to feel the benefits of a healthy living.”

For more health articles visit www.foxnews.com/health/health

Osborn noted that these drugs are not cosmetic but therapeutic.

“I saw what I could do first hand: a reduction in body fat, inflammation, glucose, triglyceride and insulin resistance – is a significant decrease in the incidence of stroke and heart attack.”

“I believe this is a signal aimed at Big Pharma.”

President Donald Trump’s administration recently announced that Medicare and Medicaid will not cover medication, as the MEDICARE and Medicaid Services centers said late Friday.

Osborn said that the coverage of coverage blocking probably had nothing to do with efficiency.

“Trump knows these drugs are acting,” Osborn said. “I believe this is a signal aimed at Big Pharma:” Reduce the price, or Medicare, the largest buyer in the block, goes out. “

Click here to get the Fox News app

“This is not a cancellation – that’s an impact,” Osborn said.

“President Trump is likely to negotiate as long as the ‘price is not correct,’ relying on great pharmacy, at the same time improveing ​​the health of Americans.”